|
LYPLA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.76529999999353E-05 |
| Normal-vs-Stage3 |
1.9082957436467E-11 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.242300E-02 |
| Stage1-vs-Stage3 |
8.595600E-01 |
| Stage1-vs-Stage4 |
6.319200E-01 |
| Stage2-vs-Stage3 |
1.240760E-01 |
| Stage2-vs-Stage4 |
4.362200E-02 |
| Stage3-vs-Stage4 |
9.238400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.6242562850266E-12 |
| Normal-vs-Asian |
3.580700E-03 |
| Caucasian-vs-AfricanAmerican |
1.203870E-02 |
| Caucasian-vs-Asian |
6.549200E-01 |
| AfricanAmerican-vs-Asian |
3.361400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
3.747400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
2.280900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.046600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.484980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.746020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.766800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.559600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.525800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.21920037901668E-10 |
| Normal-vs-Grade 2 |
1.63824509513688E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
2.479200E-01 |
| Grade 1-vs-Grade 3 |
8.068200E-01 |
| Grade 1-vs-Grade 4 |
7.598200E-01 |
| Grade 2-vs-Grade 3 |
2.039000E-01 |
| Grade 2-vs-Grade 4 |
5.301800E-02 |
| Grade 3-vs-Grade 4 |
2.612800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
6.32189856020204E-11 |
| ccA subtype-vs-ccB subtype |
2.990200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93178806284777E-14 |
| Normal-vs-N1 |
1.09550000004788E-06 |
| N0-vs-N1 |
8.064600E-01 |
|
|
